Amazon Great Indian Festival 2020 - Electronics
Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Amazon Great Indian Festival 2020 - Electronics
Stock Report

| More

Dr. Reddy's announces the launch of Over-the-Counter Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% and 0.1%, the store-brand equivalent of Pataday®, the Eye Allergy Drop in the U.S. Market

Posted On: 2020-09-17 00:41:19


Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as "Dr. Reddy's") today announced the launch of over-the-counter (OTC) Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% and 0.1%, the storebrand equivalents of Pataday® Once Daily Relief and Pataday® Twice Daily Relief, in the U.S. market, as approved by the U.S. Food and Drug Administration (USFDA).

Dr. Reddy's Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% and 0.1% are indicated for the temporary relief of itchy eyes due to pollen, ragweed, grass, animal hair and dander. The Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1% is also indicated for the temporary relief of red eyes.

"This launch marks the entry of Dr. Reddy's into the OTC eye care space, and is a testament to our deep capabilities in bringing store-brand equivalents of Rx-to-OTC switches to the U.S. market," says Marc Kikuchi, CEO, North America Generics, Dr. Reddy's Laboratories. "We are very excited to extend our strategic collaboration with Gland Pharma to bring these products to the market. We thank the teams at Gland and Dr. Reddy's whose hard work and efforts have enabled the execution of this launch in such a short timeframe."

The Pataday® brand had U.S. sales of approximately $31 million since the launch in March 2020 according to IRi*.

Dr. Reddy's Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% is available in a 2.5 mL bottle and Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1% is available in a 5 mL bottle size.

Pataday® is a registered trademark of Novartis AG.

Shares of DR.REDDY'S LABORATORIES LTD. was last trading in BSE at Rs.4631.55 as compared to the previous close of Rs. 4443.2. The total number of shares traded during the day was 98880 in over 10430 trades.

The stock hit an intraday high of Rs. 4651.95 and intraday low of 4411.5. The net turnover during the day was Rs. 451412307.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com

Amazon Great Indian Festival 2020 - Mobiles





Other Headlines:

Shish Industries Ltd H1FY21 PAT at Rs. 0.51 crore

L&T Technology Services Ltd Board approves dividend of Rs. 7.50

Kiri Industries Ltd updates on appeal filed at Singapore Court of Appeal

Zensar divests its non-core TPM / MVS Business

L&T Technology Services Ltd posts Q2FY21 consolidated PAT of Rs. 165.5 crore

TATA Metaliks Ltd reports net profit of Rs. 82 crore in Q2FY21

ITC Ltd.'s Jelimals Immunoz' study reveals 94% children miss 'Going to school' and 95% miss 'Meeting friends' in person

Rallis India reports Q2 Consolidated Revenues at Rs. 725 Cr, PAT at Rs. 83 Crores

Texmaco Rail & Engineering Limited announces Financial Results for Q2 and HYl of FY 2020-21

CSB Bank - Q2FY21 - Surging Ahead

Bajrang Finance Ltd board approves voluntary delisting of Remi Edelstahl Tubulars Limited

Tata Tea Gold pays a sincere ode to the revered exuberance associated with Durga Puja and West Bengal's art and culture

Titan Biotech Ltd reports Rs. 7.58 crore consolidated PAT in Q2FY21

Sagarsoft India Ltd Q2FY21 net profit up at Rs. 1.42 crore

Britannia Industries Ltd Q2FY21 consolidated PAT slips QoQ to Rs. 498.13 crores

KIOCL Ltd board approves buyback at Rs. 110 per share

Key Highlights of Bank of Maharashtra's Q2FY21 results

Hero MotoCorp launches Splendor+ Black and Accent

TCS' New Workforce Analytics Solution to Help Companies Attract and Retain the Right Digital Talent

Jamna Auto Industries Trusts Ramco for Digital Transformation

Borosil Renewables Ltd Q2FY21 PAT at Rs. 14.05 crore

Wipro buyback - Arbitrage Opportunity - ICICI Securities

HDFC Life Insurance Company Ltd reports Rs. 327.83 crore consolidated PAT in Q2

ACC Ltd reports consolidated Q3CY2020 PAT of Rs. 363.84 crore

RALLIS India Ltd posts consolidated PAT of Rs. 82.95 crore in Q2FY21

Skipper Ltd posts consolidated PAT of Rs. 12.54 crore in Q2

Century Textiles & Industries Ltd Q2FY21 consolidated net loss at Rs. 14.13 crore

CSB Bank Ltd Q2FY21 net profit up at Rs. 68.90 crore

BALCO recognized in 'The Economic Times Best Brands 2020'

Hatsun Agro Product Limited board reviews CAPEX projects

JK Cement Ltd implements additional capacity of 3 Lac TPA of white cement

MCX launches futures trading on MCX METLDEX, India's first real-time Base Metal Index

Tata Chemicals Ltd board to announce Q2, H1 results on Oct 29, 2020

Hatsun Agro Product Limited board recommends 1:3 bonus issue

Hatsun Agro Product Ltd reports Q2FY21 net profit of Rs. 65.78 crore

Bank of Maharashtra Q2FY21 consolidated PAT at Rs. 130.44 crores

ITC Mangaldeep agarbatti brand performs 'Loka Kshema Puja' for the welfare & wellbeing of all

Smruthi Organics Ltd Q2FY21 PAT zooms to Rs. 5.83 crore

Union Minister of State for Steel visits KIOCL

Cyient Collaborates with SR University to Help Advance the Field of Additive Manufacturing

Edelweiss Asset Management raises USD 900 mn (INR 6,600 cr) in ESOF III

Mahindra's All-New Thar Crosses 15,000 Bookings

Seshasayee Paper & Boards Ltd board to approve Q2, H1 results on Nov 7, 2020

Indoco Remedies Ltd board to announce quarterly results on Nov 6, 2020

Orient Cement Ltd board to consider Q2 results on Oct 29, 2020

Amarjothi Spinning Mills Ltd board to approve second quarter results on Oct 29, 2020

V-Guard Industries Ltd board to announce Q2FY21, H1FY21 results on Oct 28, 2020

Steel Strips Wheels Ltd receives export orders of nearly 5,500 wheels

Cosmo Films Ltd board to consider buy back proposal on Oct 26, 2020

Accelya Solutions India Ltd board to consider quarterly results on Oct 27, 2020







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019